Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study. [electronic resource]
Producer: 20140529Description: 1074-83 p. digitalISSN:- 1527-7755
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- blood
- Bone Marrow -- metabolism
- Carboplatin -- administration & dosage
- Child
- Child, Preschool
- Cisplatin -- administration & dosage
- Computer Simulation
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doublecortin Domain Proteins
- Doublecortin Protein
- Etoposide -- administration & dosage
- Homeodomain Proteins -- genetics
- Humans
- Induction Chemotherapy
- Infant
- Kaplan-Meier Estimate
- Microtubule-Associated Proteins -- genetics
- Neuroblastoma -- drug therapy
- Neuropeptides -- genetics
- Predictive Value of Tests
- Proportional Hazards Models
- RNA, Messenger -- blood
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Rate
- Transcription Factors -- genetics
- Tyrosine 3-Monooxygenase -- genetics
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.